International neuroblastoma pathology classification: Favorable histology group, patient age 1.5 years up to but less than 5 years, with differentiating neuroblastoma (Schwannian stroma-poor), and low mitosis-karyorrhexis index

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%

Pediatric patients with CNS leukemia had significantly better 3-year overall survival compared to adult patients, though the likelihood of achieving CNS complete remission was not significantly differ

Effect: decline; 81% vs. 28%